Literature DB >> 24609852

Is a personal history of nonmelanoma skin cancer associated with increased or decreased risk of other cancers?

Anthony J Alberg1, Alexander H Fischer.   

Abstract

Two conflicting hypotheses have been tested concerning the association between a personal history of nonmelanoma skin cancer (NMSC) and risk of other malignancies. One hypothesis is that as a marker of extensive sunlight exposure and hence vitamin D status, NMSC should be inversely associated with risk of other cancers. Alternatively, under the multiple primary cancer model, NMSC is postulated to be an informative first cancer to study as a marker of increased risk of subsequent primary cancer diagnoses. In this journal issue, Ong and colleagues report the results of a large-scale study in the United Kingdom with findings that NMSC was significantly associated with increased risk of a broad spectrum of other malignancies, with the associations stronger the younger the age of onset of NMSC. These results are consistent with the larger body of evidence on this topic, which is highly asymmetrical in favor of the multiple primary cancer hypothesis. Two divergent hypotheses have been tested, with the empirical evidence unequivocally indicating that NMSC is a marker of a high cancer risk phenotype. Future research is warranted to better characterize this association, to understand why NMSC is a marker of excess risk of other cancers, and to determine whether this association is clinically relevant. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24609852      PMCID: PMC3979589          DOI: 10.1158/1055-9965.EPI-13-1309

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  44 in total

1.  Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients.

Authors:  Mi Ryung Roh; Hyun Joon Shin; Soo Hyun Lee; Kee Yang Chung
Journal:  J Dermatol       Date:  2012-03-02       Impact factor: 4.005

2.  Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study.

Authors:  Eugene Liat Hui Ong; Raph Goldacre; Uy Hoang; Rodney Sinclair; Michael Goldacre
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03       Impact factor: 4.254

3.  Risk of subsequent cancer following invasive or in situ squamous cell skin cancer.

Authors:  Jimmy Thomas Efird; Gary D Friedman; Laurel Habel; Irene S Tekawa; Lorene M Nelson
Journal:  Ann Epidemiol       Date:  2002-10       Impact factor: 3.797

4.  Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.

Authors:  K Hemminki; C Dong
Journal:  Arch Dermatol       Date:  2000-05

5.  Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort.

Authors:  Melody J Eide; Dayna A Johnson; Gordon R Jacobsen; Richard J Krajenta; D Sudhaker Rao; Henry W Lim; Christine C Johnson
Journal:  Arch Dermatol       Date:  2011-08-15

6.  Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.

Authors:  T Milán; E Pukkala; P K Verkasalo; J Kaprio; C T Jansén; M Koskenvuo; L Teppo
Journal:  Int J Cancer       Date:  2000-07-15       Impact factor: 7.396

7.  Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community.

Authors:  Jolieke C van der Pols; Anne Russell; Ulrike Bauer; Rachel E Neale; Michael G Kimlin; Adèle C Green
Journal:  J Invest Dermatol       Date:  2012-10-18       Impact factor: 8.551

8.  Are patients with skin cancer at lower risk of developing colorectal or breast cancer?

Authors:  I Soerjomataram; W J Louwman; V E P P Lemmens; J W W Coebergh; E de Vries
Journal:  Am J Epidemiol       Date:  2008-04-17       Impact factor: 4.897

9.  New primary cancers after squamous cell skin cancer.

Authors:  M Frisch; M Melbye
Journal:  Am J Epidemiol       Date:  1995-05-15       Impact factor: 4.897

10.  Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study.

Authors:  Fengju Song; Abrar A Qureshi; Edward L Giovannucci; Charlie S Fuchs; Wendy Y Chen; Meir J Stampfer; Jiali Han
Journal:  PLoS Med       Date:  2013-04-23       Impact factor: 11.069

View more
  5 in total

Review 1.  All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Mackenzie R Wehner; Wilmarie Cidre Serrano; Adi Nosrati; Patrick Michael Schoen; Mary-Margaret Chren; John Boscardin; Eleni Linos
Journal:  J Am Acad Dermatol       Date:  2017-11-13       Impact factor: 11.527

2.  Family history of cutaneous and noncutaneous malignancies in relation to the risk of keratinocyte carcinoma coupled with another type of cancer: A case-control study.

Authors:  James Small; Catherine Flanagan; Kent Armeson; David Perry; Richard Marchell; Bruce Thiers; Anthony J Alberg
Journal:  J Am Acad Dermatol       Date:  2016-11       Impact factor: 11.527

Review 3.  Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.

Authors:  Virginia Barton; Kent Armeson; Shalaka Hampras; Laura K Ferris; Kala Visvanathan; Dana Rollison; Anthony J Alberg
Journal:  Arch Dermatol Res       Date:  2017-03-11       Impact factor: 3.017

4.  Epidemiology of Keratinocyte Carcinoma.

Authors:  David M Perry; Virginia Barton; Anthony J Alberg
Journal:  Curr Dermatol Rep       Date:  2017-05-29

5.  Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer.

Authors:  Saverio Latteri; Vito Emanuele Catania; Giulia Malaguarnera; Andrea Peri; Gaetano Bertino; Giuseppe Frazzetto; Antonio Maria Borzì; Antonio Biondi; Rosario Emanuele Perrotta; Michele Malaguarnera
Journal:  Biomedicines       Date:  2018-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.